KRONOX LAB SCIENCES LTD KRONOX NSEINFRA
Company Overview
Kronox Lab Sciences Limited manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents comprising ACS reagents, as well as LR, AR, and GR reagents; bulk ingredients that includes oral care, pharmacopoeia, food and nutraceutical, personal care and cosmetics, and veterinary pharma and animal health; and specialty chemicals, such as tartrates, citrates, hypophosphites, phosphates, hydroxides, EDTA and derivatives, ultra high purity chemicals, custom specification, and specialty anhydrous, as well as heat treatment, quenching, eutectic salt. Kronox Lab Sciences Limited was incorporated in 2008 and is based in Vadodara, India.
Why Investors Should Care
Generates a return on equity of 23.8%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 31.9%.
Net profit has compounded at 18.5% per year over the last five years.
Trades at a P/E of 21.7, below the sector median of 27.4.
Maintains a net profit margin of 27.3%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2026 Revenue of ₹101.22 Cr (+1.0% YoY); net profit ₹27.66 Cr.
- Trailing 12 Months Year-on-year growth — revenue +1.0%, earnings +8.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 1.9%, profit CAGR 18.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 1.93% |
| 1 Year: | 1.02% |
Compounded Profit Growth
| 5 Years: | 18.51% |
| 1 Year: | 8.61% |
Stock Price Performance
| 1 Year: | -24.13% |
| 6 Months: | +11.97% |
| 3 Months: | +12.09% |
| 1 Month: | -3.59% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)50.42 · Neutral
P/E of 21.67 is below the sector median of 27.45 — relatively cheaper than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 23.8%.
- Healthy ROCE of 31.9%.
- Excellent profit margin of 27.3%.
- Profit CAGR of 18.5% over 5 years.
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP ₹ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | KRONOX KRONOX LAB SCIENCES LTD NSEINFRA | 148.71 | 21.67 | ₹551.77 Cr | 0.33% | 31.94% | 23.82% | 1.93% | 18.51% |
| 2 | ULTRACEMCO UltraTech Cement Limited NIFTY50NSEINFRA | 11,659.00 | 56.84 | ₹3.44 L Cr | 0.66% | 11.90% | 10.66% | 12.40% | 17.26% |
| 3 | JSWSTEEL JSW Steel Limited NIFTY50NSEAIINFRA | 1,244.70 | 86.92 | ₹3.04 L Cr | 0.57% | 18.75% | 22.30% | 3.61% | 75.28% |
| 4 | ASIANPAINT Asian Paints Limited NIFTY50NSEINFRA | 2,675.50 | 59.31 | ₹2.57 L Cr | 1.03% | 24.41% | 20.24% | 1.10% | 1.75% |
| 5 | TATASTEEL Tata Steel Limited NIFTY50NSEAIINFRA | 187.67 | 21.70 | ₹2.34 L Cr | 2.09% | 11.32% | 10.56% | -1.59% | 7.21% |
| 6 | HINDZINC Hindustan Zinc Limited NSEINFRA | 532.50 | 16.26 | ₹2.25 L Cr | 3.91% | 61.97% | 61.13% | 5.61% | 9.58% |
| 7 | HINDALCO Hindalco Industries Limited NIFTY50NSEAIINFRA | 963.55 | 16.01 | ₹2.17 L Cr | 0.52% | 9.42% | 9.80% | 7.10% | 9.87% |
| 8 | GRASIM Grasim Industries Limited NIFTY50NSEINFRA | 3,133.10 | 56.45 | ₹2.13 L Cr | 0.31% | 4.00% | 4.80% | 14.63% | -10.06% |
| 9 | VAML Vedanta Aluminium Metal Limited NSEINFRA | 452.95 | inf | ₹1.77 L Cr | 0.00% | 41.97% | 49.39% | - | -46.32% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in INR.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 26.13 Cr | 24.29 Cr | 25.53 Cr | 25.27 Cr | 26.13 Cr |
| Cost of Revenue | 14.38 Cr | 11.76 Cr | 11.36 Cr | 11.87 Cr | 11.70 Cr |
| Gross Profit | 11.75 Cr | 12.53 Cr | 14.17 Cr | 13.41 Cr | 14.42 Cr |
| Operating Expenses | 4.36 Cr | 4.96 Cr | 5.99 Cr | 5.90 Cr | 5.56 Cr |
| Operating Income | 7.40 Cr | 7.57 Cr | 8.18 Cr | 7.50 Cr | 8.86 Cr |
| EBITDA | 8.66 Cr | 8.84 Cr | 9.69 Cr | 9.16 Cr | 11.67 Cr |
| Interest Expense | 0 | 0 | 3.92 L | 3.88 L | 3.60 L |
| Pretax Income | 8.31 Cr | 8.44 Cr | 9.18 Cr | 8.60 Cr | 10.97 Cr |
| Tax Provision | 2.00 Cr | 2.16 Cr | 2.50 Cr | 2.01 Cr | 2.97 Cr |
| Net Income | 6.32 Cr | 6.28 Cr | 6.68 Cr | 6.59 Cr | 8.00 Cr |
| Diluted EPS | 1.70 | 1.70 | 1.82 | 1.79 | 2.16 |
Profit & Loss (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 95.58 Cr | 89.86 Cr | 100.19 Cr | 101.22 Cr |
| Cost of Revenue | - | 54.88 Cr | 45.86 Cr | 49.49 Cr | 46.58 Cr |
| Gross Profit | - | 40.70 Cr | 44.00 Cr | 50.70 Cr | 54.64 Cr |
| Operating Expenses | - | 20.20 Cr | 16.63 Cr | 18.95 Cr | 22.42 Cr |
| Operating Income | - | 20.50 Cr | 27.37 Cr | 31.75 Cr | 32.22 Cr |
| EBITDA | - | 23.92 Cr | 29.90 Cr | 35.65 Cr | 39.47 Cr |
| Interest Expense | - | 9.30 L | 0 | 0 | 11.40 L |
| Pretax Income | - | 22.33 Cr | 28.61 Cr | 34.27 Cr | 37.30 Cr |
| Tax Provision | - | 5.71 Cr | 7.26 Cr | 8.80 Cr | 9.64 Cr |
| Net Income | - | 16.62 Cr | 21.35 Cr | 25.47 Cr | 27.66 Cr |
| Diluted EPS | 3.67 | 4.48 | 5.75 | 6.86 | - |
Balance Sheet (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Total Assets | - | 54.03 Cr | 73.99 Cr | 98.83 Cr | 127.52 Cr |
| Current Assets | - | 34.18 Cr | 46.60 Cr | 63.31 Cr | 78.84 Cr |
| Cash & Equivalents | - | 2.48 Cr | 2.59 Cr | 3.04 Cr | 2.75 Cr |
| Inventory | - | 9.17 Cr | 9.25 Cr | 6.37 Cr | 8.37 Cr |
| Receivables | - | 18.55 Cr | 17.65 Cr | 19.89 Cr | 21.18 Cr |
| Total Liabilities | - | 9.36 Cr | 7.69 Cr | 8.72 Cr | 11.40 Cr |
| Current Liabilities | - | 8.87 Cr | 7.67 Cr | 8.70 Cr | 10.37 Cr |
| Long Term Debt | 47.20 L | 0 | - | - | 1.00 Cr |
| Total Debt | 3.36 Cr | 0 | - | - | 1.61 Cr |
| Total Equity | - | 44.68 Cr | 66.31 Cr | 90.10 Cr | 116.13 Cr |
| Shares Outstanding | - | 3.71 Cr | 3.71 Cr | 3.71 Cr | 3.71 Cr |
Cash Flows (Annual)
Figures in INR.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 19.66 Cr | 17.42 Cr | 30.70 Cr | 23.89 Cr |
| Investing Cash Flow | - | -5.52 Cr | -17.31 Cr | -28.39 Cr | -23.82 Cr |
| Financing Cash Flow | - | -13.40 Cr | 0 | -1.85 Cr | -36.20 L |
| Capital Expenditure | - | -8.41 Cr | -12.27 Cr | -3.10 Cr | -3.31 Cr |
| Free Cash Flow | - | 11.25 Cr | 5.14 Cr | 27.59 Cr | 20.59 Cr |
| Net Change in Cash | - | 75.20 L | 10.29 L | 44.80 L | -28.95 L |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | 42.6% | 49.0% | 50.6% | 54.0% |
| Operating Margin % | - | 21.4% | 30.5% | 31.7% | 31.8% |
| Net Margin % | - | 17.4% | 23.8% | 25.4% | 27.3% |
| ROE % | - | 37.2% | 32.2% | 28.3% | 23.8% |
| ROCE % | - | 45.4% | 41.3% | 35.2% | 27.5% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for KRONOX
Kronox Lab Sciences to Close Trading Window Ahead of Q1 Results - The Globe and Mail
<a href="https://news.google.com/rss/articles/CBMi3AFBVV95cUxOcVI2TEhPc2xPalJoUFM4TXZkQ3dkSlVBWjdwdElYR3RlRGVTcDlkVGJYSHROQ3k2UE9ESG9GRXdrSncyaWo1Sk1ralh2WTZRSzktaFVxb0lxaEdMeVBTd0t2UlVsNUtTRzR6X05xMW84czJmZGN1UTZJTU9SQ0JHanM4Um9KcVlZVkx6U3…
Kronox Lab Scie Standalone March 2026 Net Sales at Rs 26.13 crore, down 0.02% Y-o-Y - Moneycontrol.com
<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxOZzhjQTdzNWxoYVh4d0U2ZktVNTJueFNGWFE1WUFramVMMjdOZmxhTDhpckY5bXRtNXphbDcyMlVHNEVKcXI5VGNrblNjdHNUY2hTd1dCZDhqSXRVS0FvVDFBU1NpVGVhMXdzZmp1UV9qN0Fjam1iSF9VbGdVUWFSbTZaYjVIWFZvQWtMRG…
Kronox Lab Sciences Ltd. Share Price Live Today - CNBC TV18
<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxQeTVyZlhYUjc2Q1RCWGRFUFhWcURFMWFEZUFsQm9XbUNiT2ZCcjk0ZnVUQ2xVdXdMM2dTRmw5eXo5alJXZVBZTzJhdVB2RUEyV05QVGVReUxxajcyd0NwVTVIc0VJRk96RDRxVmNOYUU2bkRFVnhjdi11amNVODJtREZPNGE4QQ?oc=5" t…
Tech Query: SJVN, Indian Overseas Bank (IOB), Kronox Lab Sciences, IDFC First Bank. What Is The Outlook? Where Are These Stocks Headed? - BusinessLine
<a href="https://news.google.com/rss/articles/CBMitwJBVV95cUxOX1lsWGR5ckFqc1Q1bnFDMUVhMDNHMkVIUGVmaUR3dDFTMlk0X2F6ZDRVUXMySWRjZXNicHFUSXhMZGwxSlhMOTltOWF0X2ZUMTEzb0NHSld1SUFTcmJtVVF4S0NfMTZWaXJGS2VZM2FkSHdhUmFXby01OUUxZkV4U2JLTTBQQXl4M2lfTD…
KRONOX Stock Price and Chart — NSE:KRONOX - TradingView
<a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTE9UcW1UWEp5OHd6TDlIWkE1YWlxaUFzaF9wVHl5NlpVRWd6YzBCTDJtOVM3eVBkeE53SG1iclhsVlp0Wng5X0ZuNGZGR3RoOGhObU5veGxBaDBybFE?oc=5" target="_blank">KRONOX Stock Price and Chart — NSE:KRONOX</a…
KRONOX LAB SCIENCES LTD Share Price - Upstox
<a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE9oUFN6VzhRczRCbkFkX0VaRGNGRmNUTkxDTExmX2o0b2g1b0JoZUNYUnJtZ013d3VoZjVDUl94N0w3NFdUVUlJYTZZaThPOUs5UXotakVaTVZ3NEU0TC1EZ25WWjd1cy1pd2ZrY3N1VQ?oc=5" target="_blank">KRONOX LAB SCIENC…
KRONOX — Frequently Asked Questions
What is the current share price of KRONOX LAB SCIENCES LTD (KRONOX)?
As of 2026-07-15 09:52 IST, KRONOX LAB SCIENCES LTD (KRONOX) trades at ₹148.71 on NSE. Its 52-week range is ₹97.02 to ₹196.01.
What is the market capitalisation of KRONOX?
KRONOX LAB SCIENCES LTD (KRONOX) has a market capitalisation of ₹551.77 Cr on NSE.
What is the P/E ratio of KRONOX?
KRONOX trades at a trailing price-to-earnings (P/E) ratio of 21.67. The industry average P/E is 27.45. Its price-to-book (P/B) ratio is 4.76.
Does KRONOX pay a dividend?
KRONOX LAB SCIENCES LTD (KRONOX) currently offers a dividend yield of 0.33%.
What is the return on equity (ROE) of KRONOX?
KRONOX has a return on equity (ROE) of 23.82%. Its return on capital employed (ROCE) is 31.94%.
Is KRONOX a good stock to buy?
This page provides a data-driven analysis of KRONOX LAB SCIENCES LTD (KRONOX), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.